• call for care 214.379.2700

    Choice Cancer Care is here for you 9AM – 5PM Monday – Friday

    Inquiring after hours? Complete our contact form and we will be in touch as soon as possible.

    Call

  • Patientportal

    Access Your Portal To Health at Choice Cancer Care.

    Learn more about becoming a CCC Patient, including insurance information and patient rights, or login to access your personal portal for in-depth information about your health.

    LoginSign UpLearn More

  • get a second opinion

    Recent Diagnosis? Gain Confidence With A Second Opinion.

    Find out what to ask your doctor, what a second opinion could mean for you, and take the steps to get you on the right path to treat your cancer.

    Complete this form for a no obligation consultation:







    captcha

  • certified

    Choice Cancer Care is proud to be recognized by the Quality Oncology Practice Initiative (QOPI®) for excellence in quality, and safety in the administration of cancer care.

    Learn More

IMRT May Be the Better Treatment Choice for Lung Cancer Treatment

As thousands of Americans face down a diagnosis of non-small cell lung cancer each year, researchers are continually working to develop the best possible treatment methods. The aim is to beat the cancer while lowering the impacts on patients in the process. A new study out of the University of Texas is shedding light on the potential benefits intensity-modulated radiation therapy may offer.

Researchers at the Anderson Cancer Center in Houston conducted a secondary analysis of data collected during a trial. The data pertained to 482 patients who underwent radiation therapy between 2007 and 2011. Of those patients, 47 percent underwent 3-dimensional conformal radiation therapy while 53 percent were treated with IMRT. All patients also had concurrent chemotherapy.

In looking at the numbers, researchers found that IMRT appeared to ease the toxicity of treatment while also helping with chemotherapy tolerance. One of the biggest findings what that 44 percent fewer cases of severe pneumonitis developed in patients treated with IMRT despite an estimated 3.5 percent of this group having larger tumors. What’s more, about 37 percent of patients in the IMRT group were able to complete consolidative chemotherapy versus 29 percent of those who underwent 3-D CRT treatments.

While more study is needed, researchers point to the potential benefits IMRT may have in helping patients with non-small cell lung cancer. This form of radiation is considered much more highly targeted than other alternatives. Although quite effective at killing cancer cells, IMRT is delivered in a manner that minimizes damage to surrounding, healthy tissues.

People who are diagnosed with lung cancer should carefully review their treatment options with their healthcare providers. The best recommendations for treatment will hinge on a patient’s unique case. Surgical procedures, radiation and chemotherapy may all be required to effectively treat the disease or enhance longevity.

As thousands of Americans face down a diagnosis of non-small cell lung cancer each year, researchers are continually working to develop the best possible treatment methods. The aim is to beat the cancer while lowering the impacts on patients in the process. A new study out of the University of Texas is shedding light on the potential benefits intensity-modulated radiation therapy may offer.

Researchers at the Anderson Cancer Center in Houston conducted a secondary analysis of data collected during a trial. The data pertained to 482 patients who underwent radiation therapy between 2007 and 2011. Of those patients, 47 percent underwent 3-dimensional conformal radiation therapy while 53 percent were treated with IMRT. All patients also had concurrent chemotherapy.

In looking at the numbers, researchers found that IMRT appeared to ease the toxicity of treatment while also helping with chemotherapy tolerance. One of the biggest findings what that 44 percent fewer cases of severe pneumonitis developed in patients treated with IMRT despite an estimated 3.5 percent of this group having larger tumors. What’s more, about 37 percent of patients in the IMRT group were able to complete consolidative chemotherapy versus 29 percent of those who underwent 3-D CRT treatments.

While more study is needed, researchers point to the potential benefits IMRT may have in helping patients with non-small cell lung cancer. This form of radiation is considered much more highly targeted than other alternatives. Although quite effective at killing cancer cells, IMRT is delivered in a manner that minimizes damage to surrounding, healthy tissues.

People who are diagnosed with lung cancer should carefully review their treatment options with their healthcare providers. The best recommendations for treatment will hinge on a patient’s unique case. Surgical procedures, radiation and chemotherapy may all be required to effectively treat the disease or enhance longevity.

Cancer Screening Guidelines

Screening can help doctors discover and treat some types of cancer early. Usually, cancer treatment is more effective when the disease is detected in its early stages and there could be a better chance of curing the cancer. Some...

Learn More

Save Your Hair During Chemo

We offer the Chemo Cold Caps Solution for patients seeking to save their hair while undergoing chemotherapy.  The Chemotherapy Cold Caps program can be accessed at any of our North Texas clinics. At Choice Cancer Care we know that being diagnosed with...

Learn More

Learn About Your Options

Your journey with cancer is influenced by several factors. These factors include your overall condition, the specific characteristics of your cancer, and whether the goal of treatment is to eradicate your cancer, stop your cancer from spreading to other areas...

Learn More